Extracellular cleaved HER2 (p95) confers partial resistance to trastuzumab but not HSP90 inhibitors in models of HER2 amplified breast cancer Meeting Abstract

  


Authors: Chandarlapaty, S.; Scaltriti, M.; Baselga, J.; Ye, Q.; Solit, D.; Norton, L.; Rosen, N.
Abstract Title: Extracellular cleaved HER2 (p95) confers partial resistance to trastuzumab but not HSP90 inhibitors in models of HER2 amplified breast cancer
Meeting Title: 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 25
Issue: 18 Suppl.
Meeting Dates: 2007 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2007-06-20
Start Page: 568s
Language: English
ACCESSION: WOS:000455043703002
PROVIDER: wos
DOI: 10.1200/jco.2007.25.18_suppl.10515
Notes: Meeting Abstract: 10515 -- Source: Wos
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Larry Norton
    758 Norton
  2. Neal Rosen
    425 Rosen
  3. David Solit
    780 Solit
  4. Sarat Chandarlapaty
    280 Chandarlapaty
  5. Qing Ye
    25 Ye
Related MSK Work